Inventor
GIRIJAVALLABHAN VIYYOOR M
US116 patents
⚠️ This page may combine multiple inventors who share the name “GIRIJAVALLABHAN VIYYOOR M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SCHERING CORP
44 patentsUS6911428B2Jun 28, 2005
Diaryl peptides as NS3-serine protease inhibitors of hepatitis C virus
SCHERING CORP124 citations98
US6403564B1Jun 11, 2002
Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection
SCHERING CORP122 citations97
US6372747B1Apr 16, 2002
Farnesyl protein transferase inhibitors
SCHERING CORP93 citations97
US6362188B1Mar 26, 2002
Farnesyl protein transferase inhibitors
SCHERING CORP85 citations97
US6277830B1Aug 21, 2001
5′-amino acid esters of ribavirin and the use of same to treat hepatitis C with interferon
SCHERING CORP120 citations97
US6919341B2Jul 19, 2005
Imidazopyrazines as cyclin dependent kinase inhibitors
SCHERING CORP65 citations96
US6432959B1Aug 13, 2002
Inhibitors of farnesyl-protein transferase
SCHERING CORP75 citations96
US6239140B1May 29, 2001
Compounds useful for inhibition of farnesyl protein transferase
SCHERING CORP64 citations96
US5750532AMay 12, 1998
Pharmaceutically active compounds
SCHERING CORP68 citations96
US5661151AAug 26, 1997
Tetrahydrofuran antifungals
SCHERING CORP69 citations96
US5459144AOct 17, 1995
Pharmaceutically active compounds
SCHERING CORP64 citations96
US5272167ADec 21, 1993
Pharmaceutically active compounds
SCHERING CORP104 citations96
US4851423AJul 25, 1989
Pharmaceutically active compounds
SCHERING CORP86 citations96
US7205330B2Apr 17, 2007
Inhibitors of hepatitis C virus NS3 protease
SCHERING CORP54 citations95
US6225322B1May 1, 2001
Compounds useful for inhibition of farnesyl protein transferase
SCHERING CORP59 citations95
US6096757AAug 1, 2000
Method for treating proliferative diseases
SCHERING CORP91 citations95
US7442695B2Oct 28, 2008
Depeptidized inhibitors of hepatitis C virus NS3 protease
SCHERING CORP22 citations93
US7399749B2Jul 15, 2008
Substituted prolines as inhibitors of hepatitis C virus NS3 serine protease
SCHERING CORP21 citations93
US7253160B2Aug 7, 2007
Depeptidized inhibitors of hepatitis C virus NS3 protease
SCHERING CORP39 citations93
US5714490AFeb 3, 1998
Tetrahydrofuran antifungals
SCHERING CORP37 citations93
US5693626ADec 2, 1997
Tetrahydrofuran antifungals
SCHERING CORP24 citations93
US5039676AAug 13, 1991
Tri- and tetra-substituted-oxetanes and tetrahydrofurans and intermediates thereof
SCHERING CORP54 citations93
US7342041B2Mar 11, 2008
3,4-(cyclopentyl)-fused proline compounds as inhibitors of hepatitis C virus NS3 serine protease
SCHERING CORP28 citations92
US7192957B2Mar 20, 2007
Compounds as inhibitors of hepatitis C virus NS3 serine protease
SCHERING CORP28 citations92
US7186747B2Mar 6, 2007
Compounds as inhibitors of hepatitis C virus NS3 serine protease
SCHERING CORP47 citations92
US7173057B2Feb 6, 2007
Ketoamides with cyclic P4'S as inhibitors of NS3 protease of hepatitis C virus
SCHERING CORP44 citations92
US6894072B2May 17, 2005
Compounds as NS3-serine protease inhibitors of hepatitis C virus
SCHERING CORP59 citations92
US5403937AApr 4, 1995
Process for preparing intermediates for the synthesis of antifungal agents
SCHERING CORP21 citations92
US4530793AJul 23, 1985
Processes for the production of penems
SCHERING CORP30 citations92
US4443373AApr 17, 1984
Process for the production of antibiotic penems
SCHERING CORP27 citations92
US7425576B2Sep 16, 2008
Compounds as inhibitors of hepatitis C virus NS3 serine protease
SCHERING CORP20 citations91
US6333333B1Dec 25, 2001
Methods for treating proliferative diseases
SCHERING CORP22 citations90
US7592419B2Sep 22, 2009
Macrocyclic inhibitors of hepatitis C virus NS3-serine protease
SCHERING CORP11 citations84
US7449447B2Nov 11, 2008
Peptidomimetic NS3-serine protease inhibitors of hepatitis C virus
SCHERING CORP20 citations83
US7423058B2Sep 9, 2008
Inhibitors of hepatitis C virus NS3 protease
SCHERING CORP15 citations83
US6992080B2Jan 31, 2006
Imidazopyridines as cyclin dependent kinase inhibitors
SCHERING CORP7 citations74
US6426352B1Jul 30, 2002
Sulfonamide inhibitors of farnesyl-protein transferase
SCHERING CORP10 citations74
US5965570AOct 12, 1999
Tricyclic piperidinyl compounds useful as inhibitors of farnesyl-protein transferase
SCHERING CORP10 citations74
US5710154AJan 20, 1998
Tetrahydrofuran antifungals
SCHERING CORP13 citations74
US5703236ADec 30, 1997
Tetrahydrofuran antifungals
SCHERING CORP11 citations74
US5703079ADec 30, 1997
Tetrahydrofuran antifungals
SCHERING CORP16 citations74
US4999428AMar 12, 1991
Process for preparing cyclopentyl purine derivatives
SCHERING CORP12 citations74
US4614738ASep 30, 1986
2-(N-heterocycloaliphaticthio)penems
SCHERING CORP7 citations74
US4584133AApr 22, 1986
Process for the production of penems
SCHERING CORP12 citations74
PHARMACOPEIA DRUG DISCOVERY
4 patentsUS6903131B2Jun 7, 2005
3,4-di-substituted maleimide compounds as CXC chemokine receptor antagonists
PHARMACOPEIA DRUG DISCOVERY28 citations92
US7161003B1Jan 9, 2007
Pyrazolopyrimidines as cyclin dependent kinase inhibitors
PHARMACOPEIA DRUG DISCOVERY32 citations91
US7119200B2Oct 10, 2006
Pyrazolopyrimidines as cyclin dependent kinase inhibitors
PHARMACOPEIA DRUG DISCOVERY45 citations91
US7078525B2Jul 18, 2006
Pyrazolopyrimidines as cyclin dependent kinase inhibitors
PHARMACOPEIA DRUG DISCOVERY15 citations84
BENNETT FRANK
1 patentGUZI TIMOTHY J
1 patentShowing the top 50 of 116 patents by PatentIndex Score.